Total Payments
$2,624
2024 Payments
$459.05
Companies
24
Transactions
191
Medicare Patients
6,877
Medicare Billing
$311,521
Payment Breakdown by Category
Food & Beverage$2,624 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,624 | 191 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $558.07 | 48 | $0 (2024) |
| Amgen Inc. | $500.49 | 49 | $0 (2024) |
| ABBVIE INC. | $343.66 | 24 | $0 (2024) |
| Lilly USA, LLC | $162.13 | 10 | $0 (2024) |
| GlaxoSmithKline, LLC. | $156.65 | 8 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $111.32 | 6 | $0 (2024) |
| PFIZER INC. | $108.35 | 6 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $89.07 | 6 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $81.12 | 6 | $0 (2023) |
| Dynavax Technologies Corporation | $70.29 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $459.05 | 23 | Novo Nordisk Inc ($72.42) |
| 2023 | $877.34 | 61 | Amgen Inc. ($170.78) |
| 2022 | $643.07 | 55 | Novo Nordisk Inc ($158.85) |
| 2021 | $644.16 | 52 | Amgen Inc. ($163.53) |
All Payment Transactions
191 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: Spinal Cord Stimulator | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/30/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Cardio-renal | ||||||
| 09/19/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Inflammation | ||||||
| 09/09/2024 | Philips North America LLC | (CK7) Extended Holter (Device) | Food and Beverage | Cash or cash equivalent | $21.91 | General |
| Category: Medical Device | ||||||
| 08/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Diabetes | ||||||
| 07/09/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Gastroenterology | ||||||
| 06/13/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: VACCINES | ||||||
| 06/05/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $26.56 | General |
| Category: NEUROSCIENCE | ||||||
| 05/20/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Inflammation | ||||||
| 05/07/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: Gastroenterology | ||||||
| 04/24/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $29.15 | General |
| Category: Hepatitis B Vaccine | ||||||
| 03/27/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $31.27 | General |
| Category: Biological | ||||||
| 03/18/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: VACCINES | ||||||
| 03/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: Gastroenterology | ||||||
| 03/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Diabetes | ||||||
| 02/21/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: Hepatitis B Vaccine | ||||||
| 02/21/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: Hepatitis B Vaccine | ||||||
| 02/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: Obesity | ||||||
| 01/24/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: RESPIRATORY | ||||||
| 12/13/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: Inflammation | ||||||
| 12/12/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 1,739 | 2,354 | $240,146 | $77,166 |
| 2022 | 34 | 1,855 | 2,550 | $256,171 | $85,578 |
| 2021 | 39 | 2,303 | 3,218 | $279,984 | $106,362 |
| 2020 | 21 | 980 | 1,305 | $118,799 | $42,414 |
Total Patients
6,877
Total Services
9,427
Medicare Billing
$311,521
Procedure Codes
128
All Medicare Procedures & Services
128 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 259 | 563 | $88,954 | $28,484 | 32.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 110 | 110 | $36,300 | $11,306 | 31.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 107 | 147 | $33,810 | $8,747 | 25.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 108 | 108 | $25,056 | $7,132 | 28.5% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 59 | 66 | $5,874 | $3,223 | 54.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 161 | 248 | $3,368 | $1,987 | 59.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 112 | 112 | $5,600 | $1,610 | 28.7% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 75 | 95 | $3,800 | $1,564 | 41.2% |
| 87634 | Detection test by nucleic acid for respiratory syncytial virus, amplified probe technique | Office | 2023 | 21 | 22 | $2,728 | $1,514 | 55.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 114 | 143 | $3,003 | $1,459 | 48.6% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 12 | 12 | $5,712 | $1,450 | 25.4% |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | Office | 2023 | 15 | 15 | $2,985 | $1,408 | 47.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 96 | 124 | $2,356 | $943.64 | 40.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 59 | 69 | $2,208 | $879.04 | 39.8% |
| 82306 | Vitamin d-3 level | Office | 2023 | 26 | 28 | $1,932 | $783.27 | 40.5% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 37 | 42 | $3,444 | $761.43 | 22.1% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 17 | 17 | $2,091 | $542.56 | 25.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 51 | 55 | $1,265 | $514.08 | 40.6% |
| 83880 | Natriuretic peptide (heart and blood vessel protein) level | Office | 2023 | 11 | 11 | $880.00 | $423.17 | 48.1% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 15 | 15 | $1,020 | $349.02 | 34.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 73 | 126 | $756.00 | $271.22 | 35.9% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 19 | 20 | $720.00 | $268.15 | 37.2% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 23 | 31 | $527.00 | $235.00 | 44.6% |
| 74018 | X-ray of abdomen, 1 view | Office | 2023 | 15 | 15 | $1,095 | $217.83 | 19.9% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2023 | 11 | 11 | $418.00 | $194.59 | 46.6% |
About Kimberly Borris, P.A
Kimberly Borris, P.A is a Medical healthcare provider based in Athens, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1174528244.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kimberly Borris, P.A has received a total of $2,624 in payments from pharmaceutical and medical device companies, with $459.05 received in 2024. These payments were reported across 191 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($2,624).
As a Medicare-enrolled provider, Borris has provided services to 6,877 Medicare beneficiaries, totaling 9,427 services with total Medicare billing of $311,521. Data is available for 4 years (2020–2023), covering 128 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical
- Location Athens, TN
- Active Since 06/16/2005
- Last Updated 07/08/2007
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1174528244
Products in Payments
- Otezla (Drug) $381.98
- VRAYLAR (Drug) $217.91
- Ozempic (Drug) $170.09
- Rybelsus (Drug) $152.34
- TRULICITY (Drug) $147.21
- Saxenda (Drug) $128.82
- XIFAXAN (Drug) $111.32
- Wegovy (Drug) $106.82
- UBRELVY (Drug) $104.94
- SHINGRIX (Biological) $99.93
- XARELTO (Drug) $89.07
- PREVNAR 20 (Biological) $80.64
- EVENITY (Biological) $76.86
- Heplisav-B (Drug) $70.29
- Kerendia (Drug) $62.31
- AREXVY (Drug) $56.72
- ELIQUIS (Drug) $51.18
- FARXIGA (Drug) $39.44
- Veozah (Drug) $31.27
- LEQVIO (Drug) $30.33
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Doctors in Athens
Charles Davis, Pa, PA
Medical — Payments: $13,708
Medical $13,708
Anna Mcfather, Pa-C, PA-C
Medical — Payments: $11,736
Medical $11,736
Megan Duncan, Pa-C, PA-C
Medical — Payments: $7,409
Medical $7,409
Kayla Weaver
Medical — Payments: $6,268
Medical $6,268
Jonathan Nix, Pa, PA
Medical — Payments: $5,163
Medical $5,163
Joel Brooker, Pa-C, PA-C
Medical — Payments: $3,372
Medical $3,372